Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseVeronika Bachanová, Daniel J. Weisdorf, M-J Zhang et al.|Leukemia|2013Cited by 136